The Peroxisome Proliferator-Activated Receptor γ Agonist Pioglitazone Preserves Bone Microarchitecture in Experimental Arthritis by Reducing the Interleukin-17-Dependent Osteoclastogenic Pathway
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Peroxisome Proliferator-Activated Receptor γ Agonist Pioglitazone Preserves Bone Microarchitecture in Experimental Arthritis by Reducing the Interleukin-17-Dependent Osteoclastogenic Pathway
Authors
Keywords
-
Journal
ARTHRITIS AND RHEUMATISM
Volume 65, Issue 12, Pages 3084-3095
Publisher
Wiley
Online
2013-08-28
DOI
10.1002/art.38130
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A novel isoform of the orphan receptor RORγt suppresses IL-17 production in human T cells
- (2012) T Rauen et al. GENES AND IMMUNITY
- JNK1, but Not JNK2, Is Required in Two Mechanistically Distinct Models of Inflammatory Arthritis
- (2011) Katja Denninger et al. AMERICAN JOURNAL OF PATHOLOGY
- Micro-CT imaging analysis for the effect of celecoxib, a cyclooxygenase-2 inhibitor, on inflammatory bone destruction in adjuvant arthritis rats
- (2011) Masahiro Noguchi et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand
- (2011) Laura A. Solt et al. NATURE
- IL-17A Expression Is Localised to Both Mononuclear and Polymorphonuclear Synovial Cell Infiltrates
- (2011) Ellen M. Moran et al. PLoS One
- Chronic arthritis leads to disturbances in the bone collagen network
- (2010) Joana Caetano-Lopes et al. ARTHRITIS RESEARCH & THERAPY
- PPAR-γ agonist rosiglitazone prevents inflammatory periodontal bone loss by inhibiting osteoclastogenesis
- (2009) Márcio Y. Hassumi et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- The nuclear receptor PPARγ selectively inhibits Th17 differentiation in a T cell–intrinsic fashion and suppresses CNS autoimmunity
- (2009) Luisa Klotz et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Peroxisome proliferator-activated receptor-γ (PPAR-γ) ligands as potential therapeutic agents to treat arthritis
- (2009) Costas Giaginis et al. PHARMACOLOGICAL RESEARCH
- Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)α agonist fenofibrate and the PPARγ agonist pioglitazone
- (2009) Unni Syversen et al. BMC Endocrine Disorders
- The dynamic interplay between osteoclasts and the immune system
- (2008) Tomoki Nakashima et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Functions of RANKL/RANK/OPG in bone modeling and remodeling
- (2008) Brendan F. Boyce et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- A key role for G-CSF-induced neutrophil production and trafficking during inflammatory arthritis
- (2008) J. L. Eyles et al. BLOOD
- T Helper 17 Lineage Differentiation Is Programmed by Orphan Nuclear Receptors RORα and RORγ
- (2008) Xuexian O. Yang et al. IMMUNITY
- The differentiation of human TH-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORγt
- (2008) Nicolas Manel et al. NATURE IMMUNOLOGY
- Wnt Pathway and IL-17: Novel Regulators of Joint Remodeling in Rheumatic Diseases. Looking Beyond the RANK-RANKL-OPG Axis
- (2008) Dimitrios Daoussis et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis
- (2008) Meriem Koufany et al. ARTHRITIS RESEARCH & THERAPY
- Effects of risedronate in a rat model of osteopenia due to orchidectomy and disuse: Densitometric, histomorphometric and microtomographic studies
- (2007) Hélène Libouban et al. MICRON
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started